Work

SU2C phase Ib study of the PI3Kα inhibitor BYL719 with letrozole in ER+/HER2– metastatic breast cancer (MBC).

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.516

Authors: Ingrid A. Mayer, Vandana Gupta Abramson, Justin M. Balko, Melinda Sanders, Dejan Juric, Yisheng Li, Lewis Cantley, Eric P. Winer, Carlos L. Arteaga

Institutions: Vanderbilt University, Vanderbilt-Ingram Cancer Center, Harvard University, Massachusetts General Hospital, The University of Texas MD Anderson Cancer Center, Weill Cornell Medicine, Dana-Farber Cancer Institute

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4234951490

Cites:

Cited by: 3

Related to: 10